KAI407 is a potent non-8-aminoquinoline compound that kills Plasmodium cynomolgi early dormant liver stage parasites in vitro. KAI407 showed an activity profile similar to that of primaquine (PQ), efficiently killing the earliest stages of the parasites that become either primary hepatic schizonts or hypnozoites (50% inhibitory concentration [IC50] for hypnozoites, KAI407, 0.69 µM, and PQ, 0.84 µM, for developing liver stages, KAI407, 0.64 µM, and PQ, 0.37 µM). KAI407 may represent a new compound class for P. vivax malaria prophylaxis and potentially a radical cure.
Molekulargewicht:
421.37
CAS Nummer:
[1513879-18-9]
Formel:
C22H14F3N5O
Target-Kategorie:
Others
T70507
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
